Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116100433 | 11610043 | 3 | F | 20130808 | 20160404 | 20150916 | 20160805 | PER | US-ELI_LILLY_AND_COMPANY-US201308003548 | ELI LILLY AND CO | 65.31 | YR | F | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116100433 | 11610043 | 1 | PS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 28 U, BID | Y | C106291H | 20563 | 28 | IU | INJECTION | BID | ||||
| 116100433 | 11610043 | 2 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 30 U, EACH MORNING | Y | 20563 | 30 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 3 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 30 U, EACH EVENING | Y | 20563 | 30 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 4 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 35 U, EACH MORNING | Y | 20563 | 35 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 5 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 35 U, EACH EVENING | Y | 20563 | 35 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 6 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 60 U, EACH MORNING | Y | 20563 | 60 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 7 | SS | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 60 U, EACH EVENING | Y | 20563 | 60 | IU | INJECTION | QD | |||||
| 116100433 | 11610043 | 8 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 30 U, BEFORE EACH MEAL | Y | 0 | 30 | IU | INJECTION | ||||||
| 116100433 | 11610043 | 9 | C | VICTOZA | LIRAGLUTIDE | 1 | UNK, EACH MORNING | U | U | 0 | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116100433 | 11610043 | 1 | Type 2 diabetes mellitus |
| 116100433 | 11610043 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116100433 | 11610043 | Blood glucose increased | |
| 116100433 | 11610043 | Glycosylated haemoglobin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116100433 | 11610043 | 1 | 2012 | 0 | ||
| 116100433 | 11610043 | 6 | 201602 | 0 | ||
| 116100433 | 11610043 | 7 | 201602 | 0 | ||
| 116100433 | 11610043 | 8 | 201602 | 0 |